SCHOTT Pharma KGaA Balance Sheet Health
Financial Health criteria checks 5/6
SCHOTT Pharma KGaA has a total shareholder equity of €769.3M and total debt of €188.4M, which brings its debt-to-equity ratio to 24.5%. Its total assets and total liabilities are €1.4B and €629.7M respectively. SCHOTT Pharma KGaA's EBIT is €186.1M making its interest coverage ratio 41. It has cash and short-term investments of €22.2M.
Key information
24.5%
Debt to equity ratio
€188.40m
Debt
| Interest coverage ratio | 41x |
| Cash | €22.15m |
| Equity | €769.31m |
| Total liabilities | €629.73m |
| Total assets | €1.40b |
Recent financial health updates
These 4 Measures Indicate That SCHOTT Pharma KGaA (ETR:1SXP) Is Using Debt Reasonably Well
Nov 25
We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt
Jun 07Recent updates
These 4 Measures Indicate That SCHOTT Pharma KGaA (ETR:1SXP) Is Using Debt Reasonably Well
Nov 25SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Business Is Trailing The Market But Its Shares Aren't
Oct 27SCHOTT Pharma AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Sep 01Is There An Opportunity With SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) 31% Undervaluation?
Aug 07Earnings Miss: SCHOTT Pharma AG & Co. KGaA Missed EPS By 18% And Analysts Are Revising Their Forecasts
Jul 01We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt
Jun 07Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Mar 28Financial Position Analysis
Short Term Liabilities: 1SXP's short term assets (€586.0M) exceed its short term liabilities (€415.6M).
Long Term Liabilities: 1SXP's short term assets (€586.0M) exceed its long term liabilities (€214.1M).
Debt to Equity History and Analysis
Debt Level: 1SXP's net debt to equity ratio (21.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1SXP's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1SXP's debt is well covered by operating cash flow (101.4%).
Interest Coverage: 1SXP's interest payments on its debt are well covered by EBIT (41x coverage).